Contact Us
Gene Therapy Clinical Trial Services Global Market Report 2025
Global Gene Therapy Clinical Trial Services Market Report 2025
Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Gene Therapy Clinical Trial Services Global Market Report 2025

By Type (Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types), By Application (Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications), By End-User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gene Therapy Clinical Trial Services Market Overview

• Gene Therapy Clinical Trial Services market size has reached to $1.53 billion in 2024

• Expected to grow to $3.69 billion in 2029 at a compound annual growth rate (CAGR) of 19.2%

• Growth Driver: The Increasing Demand For Personalized Medicine Is Fueling The Growth Of The Market Due To Advancements In Genomics And Tailored Therapeutic Approaches

• Market Trend: Innovative Decentralized Clinical Trial Platforms Transforming Gene Therapy Research

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gene Therapy Clinical Trial Services Market?

Gene therapy clinical trial services refer to the specialized support, infrastructure, and expertise provided to design, manage, and conduct clinical trials that evaluate gene therapy products in humans. These services encompass a wide range of activities to ensure that investigational gene therapies are tested safely, ethically, and efficiently, while generating reliable clinical evidence to support regulatory approval and potential commercialization.

The main types of gene therapy clinical trial services are clinical trial design and planning, supply and logistics services, regulatory services, data management and biostatistics, site management and monitoring, and others. Clinical trial design and planning is the process of outlining a study’s objectives, methods, timelines, and analysis to ensure it is scientifically valid and compliant with regulations. These services, applied across various applications, include oncology, hematology, endocrine or metabolic disorders, musculoskeletal diseases, cardiovascular diseases, neurology disorders, infectious diseases, ophthalmology, immunology, and others, and cater to several end users such as pharmaceutical companies, biotechnology firms, academic institutions, government research institutes, and contract research organizations.

Gene Therapy Clinical Trial Services Market Size and growth rate 2025 to 2029: Graph

What Is The Gene Therapy Clinical Trial Services Market Size 2025 And Growth Rate?

The gene therapy clinical trial services market size has grown rapidly in recent years. It will grow from $1.53 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 19.6%. The growth in the historic period can be attributed to increasing research and development investment, rising prevalence of rare genetic disorders, growing adoption of precision medicine approaches, increasing regulatory support through accelerated approval pathways, and a rising number of gene therapy candidates.

What Is The Gene Therapy Clinical Trial Services Market Growth Forecast?

The gene therapy clinical trial services market size is expected to see rapid growth in the next few years. It will grow to $3.69 billion in 2029 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to growing technological advancements in gene-editing tools, a growing number of clinical trials, rising demand for personalized treatment, growing investment in manufacturing infrastructure for cell and gene therapies, and increasing patient recruitment efforts. Major trends in the forecast period include advancements in gene-editing technologies, advancements in vector manufacturing capabilities, advancements in patient recruitment strategies, integration of real-world evidence, and integration of the decentralized trial model.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Gene Therapy Clinical Trial Services Market Segmented?

1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types

2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design

2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage

3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring

4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling

5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits

6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention

What Is Driving The Gene Therapy Clinical Trial Services Market? The Increasing Demand For Personalized Medicine Is Fueling The Growth Of The Market Due To Advancements In Genomics And Tailored Therapeutic Approaches

The increasing demand for personalized medicine is expected to propel the growth of the gene therapy clinical trial services market going forward. Personalized medicine is an approach that tailors medical treatment to individual characteristics, such as genetic, biomarker, and lifestyle factors. The personalized medicine demand is rising due to advancements in genomics and biotechnology, which enable more precise targeting of therapies. Gene therapy clinical trial services support personalized medicine by analyzing patient-specific genetic profiles and customizing treatments accordingly, using biomarker analysis and companion diagnostics to optimize therapy for each individual while enhancing safety and effectiveness. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the gene therapy clinical trial services industry.

Who Are The Major Players In The Global Gene Therapy Clinical Trial Services Market?

Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Poseida Therapeutics Inc., Veristat LLC, Genprex Inc., Novotech Health Holdings Pte Limited, bluebird bio Inc.

What Are The Key Trends Of The Global Gene Therapy Clinical Trial Services Market? Innovative Decentralized Clinical Trial Platforms Transforming Gene Therapy Research

Major companies operating in the gene therapy clinical trial services market are focusing on developing innovative solutions such as long-term follow-up (LTFU) model for cell and gene therapy (CGT) trials to accelerate the overall trial process while maintaining regulatory compliance and safety standards. A Long-Term Follow-Up (LTFU) model for cell and gene therapy (CGT) trials is a structured framework designed to monitor patients over an extended period, often up to 15 years after receiving a CGT treatment. For instance, in May 2025, Medable Inc., a US-based SaaS company, launched a digital-first Long-Term Follow-Up (LTFU) model specifically designed for cell and gene therapy (CGT) trials. It supports cell and gene therapy trials by reducing patient and site burdens while ensuring scientific rigor over the FDA-required 15-year monitoring period. It improves patient access, retention, and data continuity through remote and hybrid follow-up methods, enhancing long-term safety and efficacy monitoring.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Gene Therapy Clinical Trial Services Market? Kyowa Kirin Co., Ltd. Acquired Orchard Therapeutics Plc To Boost Gene Therapy And Rare Disease Treatment

In January 2024, Kyowa Kirin Co., Ltd., a Japan-based pharmaceutical company, acquired Orchard Therapeutics plc for an undisclosed amount. Through this acquisition, Kyowa Kirin aims to enhance its gene therapy capabilities and expand its presence in the advanced therapies industry, particularly focusing on rare diseases and genetic disorders. Orchard Therapeutics plc is a UK-based biotechnology company that offers gene therapy clinical trial services.

What Is The Regional Outlook For The Global Gene Therapy Clinical Trial Services Market?

North America was the largest region in the gene therapy clinical trial services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Therapy Clinical Trial Services Market?

The gene therapy clinical trial services market includes revenues earned by entities by providing services such as patient recruitment and enrollment, clinical trial site selection and setup, pharmacovigilance and safety monitoring, biomarker analysis and companion diagnostics, and training and support for clinical staff. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gene Therapy Clinical Trial Services Industry?

The gene therapy clinical trial services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene therapy clinical trial services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Gene Therapy Clinical Trial Services Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.82 billion
Revenue Forecast In 2034 $3.69 billion
Growth Rate CAGR of 19.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Type, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Poseida Therapeutics Inc., Veristat LLC, Genprex Inc., Novotech Health Holdings Pte Limited, bluebird bio Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Gene Therapy Clinical Trial Services Market Characteristics

3. Gene Therapy Clinical Trial Services Market Trends And Strategies

4. Gene Therapy Clinical Trial Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gene Therapy Clinical Trial Services Growth Analysis And Strategic Analysis Framework

5.1. Global Gene Therapy Clinical Trial Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Gene Therapy Clinical Trial Services Market Growth Rate Analysis

5.4. Global Gene Therapy Clinical Trial Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Gene Therapy Clinical Trial Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Gene Therapy Clinical Trial Services Total Addressable Market (TAM)

6. Gene Therapy Clinical Trial Services Market Segmentation

6.1. Global Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Trial Design And Planning

Supply And Logistics Services

Regulatory Services

Data Management And Biostatistics

Site Management And Monitoring

Other Types

6.2. Global Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Hematology

Endocrine Or Metabolic Disorders

Musculoskeletal Diseases

Cardiovascular Diseases

Neurology Disorders

Infectious Diseases

Ophthalmology

Immunology

Other Applications

6.3. Global Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Biotechnology Companies

Academic Institutions

Government Research Institutes

Contract Research Organizations (CROs)

6.4. Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Clinical Trial Design And Planning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protocol Development

Feasibility Studies

Patient Recruitment Strategy Design

6.5. Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Supply And Logistics Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cold Chain Management

Investigational Product Packaging And Labeling

Controlled-Temperature Storage

6.6. Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Regulatory Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Regulatory Consulting And Strategy

Ethics Committee Submissions

Regulatory Compliance Monitoring

6.7. Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Data Management And Biostatistics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Data Capture And Database Design

Data Validation And Quality Control

Statistical Analysis And Modeling

6.8. Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Site Management And Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Site Selection And Qualification

Investigator Training And Support

On-Site Monitoring Visits

6.9. Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmacovigilance And Safety Reporting

Quality Assurance And Auditing

Patient Engagement And Retention

7. Gene Therapy Clinical Trial Services Market Regional And Country Analysis

7.1. Global Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Therapy Clinical Trial Services Market

8.1. Asia-Pacific Gene Therapy Clinical Trial Services Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Therapy Clinical Trial Services Market

9.1. China Gene Therapy Clinical Trial Services Market Overview

9.2. China Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Therapy Clinical Trial Services Market

10.1. India Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Therapy Clinical Trial Services Market

11.1. Japan Gene Therapy Clinical Trial Services Market Overview

11.2. Japan Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Therapy Clinical Trial Services Market

12.1. Australia Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Therapy Clinical Trial Services Market

13.1. Indonesia Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Therapy Clinical Trial Services Market

14.1. South Korea Gene Therapy Clinical Trial Services Market Overview

14.2. South Korea Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Therapy Clinical Trial Services Market

15.1. Western Europe Gene Therapy Clinical Trial Services Market Overview

15.2. Western Europe Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Therapy Clinical Trial Services Market

16.1. UK Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Therapy Clinical Trial Services Market

17.1. Germany Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Therapy Clinical Trial Services Market

18.1. France Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Therapy Clinical Trial Services Market

19.1. Italy Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Therapy Clinical Trial Services Market

20.1. Spain Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Therapy Clinical Trial Services Market

21.1. Eastern Europe Gene Therapy Clinical Trial Services Market Overview

21.2. Eastern Europe Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Therapy Clinical Trial Services Market

22.1. Russia Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Therapy Clinical Trial Services Market

23.1. North America Gene Therapy Clinical Trial Services Market Overview

23.2. North America Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Therapy Clinical Trial Services Market

24.1. USA Gene Therapy Clinical Trial Services Market Overview

24.2. USA Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Therapy Clinical Trial Services Market

25.1. Canada Gene Therapy Clinical Trial Services Market Overview

25.2. Canada Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Therapy Clinical Trial Services Market

26.1. South America Gene Therapy Clinical Trial Services Market Overview

26.2. South America Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Therapy Clinical Trial Services Market

27.1. Brazil Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Therapy Clinical Trial Services Market

28.1. Middle East Gene Therapy Clinical Trial Services Market Overview

28.2. Middle East Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Therapy Clinical Trial Services Market

29.1. Africa Gene Therapy Clinical Trial Services Market Overview

29.2. Africa Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Therapy Clinical Trial Services Market Competitive Landscape And Company Profiles

30.1. Gene Therapy Clinical Trial Services Market Competitive Landscape

30.2. Gene Therapy Clinical Trial Services Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sharp Services LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Labcorp Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Pharmaceutical Product Development LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Gene Therapy Clinical Trial Services Market Other Major And Innovative Companies

31.1. Syneos Health Inc.

31.2. WuXi AppTec

31.3. Franklin Biolabs

31.4. Catalent Inc.

31.5. Charles River Laboratories International Inc.

31.6. Parexel International (MA) Corporation

31.7. Medpace Holdings Inc.

31.8. Precision Medicine Group LLC

31.9. Worldwide Clinical Trials

31.10. IQVIA Holdings Inc.

31.11. TFS HealthScience

31.12. Poseida Therapeutics Inc.

31.13. Veristat LLC

31.14. Genprex Inc.

31.15. Novotech Health Holdings Pte Limited

32. Global Gene Therapy Clinical Trial Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Therapy Clinical Trial Services Market

34. Recent Developments In The Gene Therapy Clinical Trial Services Market

35. Gene Therapy Clinical Trial Services Market High Potential Countries, Segments and Strategies

35.1 Gene Therapy Clinical Trial Services Market In 2029 - Countries Offering Most New Opportunities

35.2 Gene Therapy Clinical Trial Services Market In 2029 - Segments Offering Most New Opportunities

35.3 Gene Therapy Clinical Trial Services Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Clinical Trial Design And Planning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Supply And Logistics Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Regulatory Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Data Management And Biostatistics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Site Management And Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Thermo Fisher Scientific Inc. Financial Performance
  • Table 81: Sharp Services LLC Financial Performance
  • Table 82: Labcorp Financial Performance
  • Table 83: Pharmaceutical Product Development LLC Financial Performance
  • Table 84: ICON plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Clinical Trial Design And Planning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Supply And Logistics Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Regulatory Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Data Management And Biostatistics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Site Management And Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Gene Therapy Clinical Trial Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Gene Therapy Clinical Trial Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Gene Therapy Clinical Trial Services Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 81: Sharp Services LLC Financial Performance
  • Figure 82: Labcorp Financial Performance
  • Figure 83: Pharmaceutical Product Development LLC Financial Performance
  • Figure 84: ICON plc Financial Performance

Frequently Asked Questions

Gene therapy clinical trial services refer to the specialized support, infrastructure, and expertise provided to design, manage, and conduct clinical trials that evaluate gene therapy products in humans. These services encompass a wide range of activities to ensure that investigational gene therapies are tested safely, ethically, and efficiently, while generating reliable clinical evidence to support regulatory approval and potential commercialization. For further insights on this market, request a sample here

The market major growth driver - The Increasing Demand For Personalized Medicine Is Fueling The Growth Of The Market Due To Advancements In Genomics And Tailored Therapeutic Approaches. For further insights on this market, request a sample here

The gene therapy clinical trial services market size has grown rapidly in recent years. It will grow from $1.53 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 19.6%. The growth in the historic period can be attributed to increasing research and development investment, rising prevalence of rare genetic disorders, growing adoption of precision medicine approaches, increasing regulatory support through accelerated approval pathways, and a rising number of gene therapy candidates. The gene therapy clinical trial services market size is expected to see rapid growth in the next few years. It will grow to $3.69 billion in 2029 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to growing technological advancements in gene-editing tools, a growing number of clinical trials, rising demand for personalized treatment, growing investment in manufacturing infrastructure for cell and gene therapies, and increasing patient recruitment efforts. Major trends in the forecast period include advancements in gene-editing technologies, advancements in vector manufacturing capabilities, advancements in patient recruitment strategies, integration of real-world evidence, and integration of the decentralized trial model. For further insights on this market, request a sample here

The gene therapy clinical trial services market covered in this report is segmented
1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types
2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs) Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design
2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage
3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring
4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling
5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits
6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention For further insights on this market,
request a sample here

North America was the largest region in the gene therapy clinical trial services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Poseida Therapeutics Inc., Veristat LLC, Genprex Inc., Novotech Health Holdings Pte Limited, bluebird bio Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Decentralized Clinical Trial Platforms Transforming Gene Therapy Research. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon